InvestorsHub Logo

Steady_T

04/23/21 11:33 AM

#308011 RE: tredenwater2 #308003

One thing that happens if BIIB gets their drug approved is that it sets cost reference for AD treatment that is going to be quite high. That will give Anvex increased pricing power in the marketplace.